NCAM1 and glioblastoma: Kaplan–Meier curves showing an association of progression-free survival probability with an elevated frequency of CD3-/CD94+ and CD3-/CD56+ NK cells were performed to evaluate the impact of NK cells in prognosis of glioblastoma patients.